BMT Program Meetings
Held every Monday
|09/08/14||Angiogenic factors in GVHD: Lessons from pregnancy||Dr. Shernan Holtan|
|09/15/14||BMT Protocol Updates|
|09/22/14||Proteomic studies in idiopathic pneumonia syndrome||Maneesh Bhargava|
|09/29/14||Update on ID Studies||JoAnne Young|
|10/06/14||Single cell analyses to understand mechanisms of AML self-renewal||Zohar Sachs, M.D., Ph.D.|
|10/13/14||Hemorrhagic cystitis: What does our experience demonstrate?||Celalettin Ushun, M.D.|
|10/20/14||Mitochondrial polymorphism and outcomes following HCT||Julie Ross, Ph.D.|
|10/27/14||Clinical consequences of early chimerism in UCB transplantation||Nelli Bejanyan, M.D.|
|11/03/14||Physician Utilization Reviews (Karyn Baum) - 30 minutes |
GVHD Disease Forms (Judy Witte) - 20 minutes
Donor consent - 10 minutes
|Karyn Baum and Judy Witte|
|11/10/14||9th Annual Children's Cancer Research Fund Norma K.C. Ramsay, M.D. Distinguished Visiting Professor Lectureshi |
Regulatory T cells and the quest for transplant tolerance
|Dr. Maria-Grazia Roncarolo |
Host: John Wagner, M.D.
|11/17.14||Genoptypic and immunophenotypic signatures of drug resistance in multiple myeloma||Michael Linden, M.D., Ph.D., Assistant Professor, Laboratory Medicine and Pathology |
Brian Van Ness, Ph.D., Professor, Genetics, Cell Biology and Development
|11/24/14||ASH Practice Talks|
|12/01/14||ASH Practice Talks|
|12/08/14||Cancelled due to ASH annual meeting|
|01/05/15||B cell receptor signatures from mRNA-seq predict outcome in basal-like breast cancer||Benjamin Vincent, M.D., Fellow, University of North Carolina Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center |
Faculty candidate, HOT Division
|01/12/15||Veronika Bachanova, M.D., Ph.D.|
|01/19;15||No conference due to Martin Luther King holiday|
|01/26/15||Vaccine approaches to control cytomegalovirus infection in stem cell transplant recipients and to prevent in utero congenital infection||Don Diamond, Ph.D. |
Chair and Professor, Department of Experimental Therapeutics
City of Hope
Host: Jeffrey Miller, M.D.
|02/16/15||Cancelled : Tandem|
Alex Lazaryan, M.D.
|03/02/15||Brian McClune, D.O.|
|03/30/15||Characterizing and Targeting Ras Signaling in AML||Craig Eckfeldt, M.D., Ph.D.|
|04/06/15||VIP Cancer Immunotherapy||Edmund Waller, M.D., Ph.D. |
Professor of Medicine, Pathology and Hematology/Oncology
Emory School of Medicine
Associate Director for Clinical Research
Winship Cancer Institute
Host: Jeffrey Miller, M.D.
Defining perfect immune reconstitution after allogeneic hematopoietic stem cell transplantation (HSCT)
Kidney transplant after hematopoietic stem cell transplant: Infections, complications, and immunosuppressive considerations
Mayada Abu Shanap, M.D.
Christen Ebens, M.D.
|04/27/15||BMT for metachromatic leukodystrophy||Weston Miller, M.D.|
|05/04/15||Developing new cellular therapies to treat GVHD following stem cell transplantation||Keli Hippen,Ph.D.|
Brian McClune, D.O.
Book Club: Being Mortal: Medicine and What Matters in the End by Atul Gawande
"In Being Mortal, bestselling author Atul Gawande tackles the hardest challenge of his profession: how medicine can not only improve life but also the process of its ending
Medicine has triumphed in modern times, transforming birth, injury, and infectious disease from harrowing to manageable. But in the inevitable condition of aging and death, the goals of medicine seem too frequently to run counter to the interest of the human spirit. Nursing homes, preoccupied with safety, pin patients into railed beds and wheelchairs. Hospitals isolate the dying, checking for vital signs long after the goals of cure have become moot. Doctors, committed to extending life, continue to carry out devastating procedures that in the end extend suffering.
Gawande, a practicing surgeon, addresses his profession's ultimate limitation, arguing that quality of life is the desired goal for patients and families. Gawande offers examples of freer, more socially fulfilling models for assisting the infirm and dependent elderly, and he explores the varieties of hospice care to demonstrate that a person's last weeks or months may be rich and dignified.
Full of eye-opening research and riveting storytelling, Being Mortal asserts that medicine can comfort and enhance our experience even to the end, providing not only a good life but also a good end."
|Erica Warlick, M.D.|
|05/25/15||Cancelled: Memorial Day Holiday|